Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant in Milk of Healthy Lactating Women
NCT04890561Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd. Primary endpoints: Cumulative Total Amount of Lemborexant Excreted in Breast Milk, Fraction of Dose Excreted in Breast Milk and 1 more. Started May 2021; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT04890561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890561.